US Edition
Published • loading... • Updated
Australia Approves First Koala Chlamydia Vaccine for Field Use
The single-dose vaccine, developed after over a decade of research, could reduce chlamydia-related mortality in wild koalas by at least 65%, aiding conservation efforts.
- Australia has approved the first koala chlamydia vaccine, allowing it to be distributed nationwide to protect koalas from the disease.
- The Australian Pesticides and Veterinary Medicines Authority confirmed that this vaccine is the first of its kind approved for use in the wild.
- Research by the University of the Sunshine Coast shows the vaccine could reduce symptoms of chlamydia and mortality rates in koalas by at least 65%.
- The Australian government is investing A$76 million into koala conservation efforts, including the vaccine rollout and habitat restoration.
Insights by Ground AI
177 Articles
177 Articles
Koala Chlamydia Vaccine Receives Australian Tick of Approval
The Australian federal government has approved a historic single-dose vaccine to protect koalas from chlamydia, a disease threatening the survival of the species. Chlamydia can cause painful infections, infertility, blindness, and death in koalas. Infection rates in some populations reach up to 70 percent, with the bacterial disease threatening the survival of koalas in eastern Australia. The vaccine was developed by researchers at the Universit…
·New York, United States
Read Full Article
Thanks to regulatory approval, the vaccine can be used in wildlife hospitals, veterinarians and conservation.
·Finland
Read Full Article
Coverage Details
Total News Sources177
Leaning Left29Leaning Right25Center77Last UpdatedBias Distribution59% Center
Bias Distribution
- 59% of the sources are Center
59% Center
L 22%
C 59%
R 19%
Factuality
To view factuality data please Upgrade to Premium
